Ming Xu
Company: Bayer
Job title: Vice President, Product Team Leader (PTL) for RED Oncology
Seminars:
Panel Discussion: Challenges and Opportunities for Securing Ongoing Funding for Radiopharmaceuticals in Europe 9:30 am
Assessing differences in US market Understanding nuances in European market to appreciate what investors are looking for Hearing what investors are looking for to secure new fundingRead more
day: Conference Day One
Designing Optimal First in Human Radiopharmaceutical Trials for Translational Success: Regulatory Considerations 2:00 pm
First-in-human radiopharmaceutical trials are critical for assessing the safety, pharmacokinetics, dosimetry, and preliminary efficacy of new radiopharmaceuticals. The design of these trials must be meticulous to ensure patient safety while gathering essential data. Key components include patient monitoring duration, dose toxicity assessment, and primary readouts. Join this workshop to: Uncover pre, during and post-treatment monitoring…Read more
day: Workshop C
Chair’s Opening Remarks 8:20 am
day: Conference Day One
Chair’s Closing Remarks 5:15 pm
day: Conference Day One
Transforming Clinical Understandings to Accelerate Radiopharmaceutical Development & Expand Treatment Efficacy 10:45 am
day: C&S Track AM